US 10323026
Heterocyclic compound
granted A61PA61P21/02A61P25/00
Quick answer
US patent 10323026 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P21/02, A61P25/00, A61P25/04, A61P25/08